June 20, 2025 10:39 pm (IST)
Follow us:
Mumbai, Mar 14 (IBNS) Pharmaceutical major Pfizer has stopped manufacture and sale of popular cough syrup Corex with immediate effect after a ban by the Government.
“This is to inform you that the Government of India has prohibited the manufacture for sale, sale and distribution of fixed dose combination of Chlopheniramine Maleate + Codeine Syrup with immediate effect,” Pfizer said in a BSE filing on Monday.
“In view of this, the company has discontinued the manufacture and sale of its drug Corex with immediate effect," it said.
Pfizer said it believed Corex had a "well-established efficacy and safety profile in India for more than 30 years," adding that the company was "exploring all possible options at its disposal."
Pfizer said the prohibition on Corex is likely to have an adverse impact on the revenue and profitability of the company.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Gaza’s health system is at breaking point, says WHO
Wed, Jun 18 2025
Air pollution has a direct link with premature birth, study finds
Sun, Jun 08 2025
Serum Institute launches conclave in Kolkata to raise awareness about HPV and cancer prevention
Fri, Jun 06 2025
AIDS still killing one person every minute, says UN
Fri, Jun 06 2025
India sees steep rise in COVID-19 infections with over 3000 active cases at present
Sun, Jun 01 2025
India's Covid-19 tally inches closer to 3,000, Kerala worst-hit
Sat, May 31 2025
WHO warns flavoured nicotine products driving youth addiction
Sat, May 31 2025